Skip to main content
Clinical Trials/NCT07264478
NCT07264478Active, not recruitingNot Applicable

Beijing Children's Hospital, Capital Medical University, China National Clinical Research Center of Respiratory Diseases, National Center for Children's Health, Beijing, China

Beijing Children's Hospital1 site in 1 country1,100 target enrollmentStarted: October 15, 2022Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
1,100
Locations
1
Primary Endpoint
hospitalization costs

Study Overview

Brief Summary

To understand the diagnosis and treatment status and medical burden of respiratory syncytial virus (RSV) infection in children in China, and to provide scientific basis for formulating prevention and treatment strategies for children. According to the seven administrative regions of China, namely Northeast, North, Northwest, Southwest, Central, South and East China, 1-3 children's medical institutions were selected from each region, and the cases of bronchiolitis or pneumonia admitted to hospitals and diagnosed as RSV positive by etiology during January 1, 2017 to December 31, 2021 were selected. Demographic data and clinical information were collected, and subgroup analysis was designed to explore the relationship between them and medical expenses and clinical treatment burden.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
0 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Hospitalized patients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia

Exclusion Criteria

  • Inpatients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia are excluded from any of the following criteria:
  • Pneumonia occurring 48 hours after hospitalization;
  • Combined with bronchial foreign body;
  • Participants in clinical trials of drugs or medical devices;
  • Not complete personal and family history and other relevant information.

Outcomes

Primary Outcomes

hospitalization costs

Time Frame: duration of hospital stay

hospitalization costs,pharmcost,testcost,testcost

Secondary Outcomes

  • hospital day(duration of hospital stay)

Investigators

Sponsor
Beijing Children's Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Baoping XU

professor

Beijing Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials